Using computer software to predict dangerous heart rhythms in people with a heart attack
Tests AI software that spots dangerous heart rhythms in adults hospitalized with sudden heart illness.
Key facts
- Who runs it
- Catharina Ziekenhuis Eindhoven
- Where
- Netherlands1 site in 1 countryChoose a country to see its sites
- Trial code
- Registry title
- Predict Arrhythmia Risk Using Intelligent Software
- Status
- Recruiting
- People taking part
- 3,000 people, planned
- Started
- 1 Jan 2023
- Expected to end
- 1 Apr 2029
- Type of study
- Observational
- Record updated
- 28 August 2026
Who can take part
The trial is looking for adults admitted for sudden heart illness or a planned heart procedure, whose heart rhythm was watched on an ECG monitor. It uses ECG data already stored, to test computer (AI) models that spot and predict dangerous heart rhythms.
- Age
- 18 years or older
- Sex
- All sexes
- Disease stage
- Admitted from 1/1/2023 for acute heart illness or after a planned heart procedure. On ECG monitoring in the CCU, ICU or ward.
- Biomarker or test result
- Continuous ECG wave data must have been routinely stored for the patient.
- Main reasons for not taking part
- People who said in the hospital's opt-out program that their data must not be used for research or to improve care
Show the full registry criteria (6)Hide the full registry criteria
Who can take part
- Patients admitted from 1/1/2023*
- Patients aged 18 years or older
- Admitted for acute cardiac illness or after elective cardiac procedures
- Who are on ECG monitoring in the CCU, ICU or ward
- Patients for whom continuous waveform ECG data have been routinely stored; Continuous waveform ECG data has been routinely stored in the CZE since 1/1/2023 on the ICU, since 1/12/2025 on the CCU and on the ward it has yet to be implemented. As our project utilizes this continuous ECG data, it will only include patients for whom this data is available
Who cannot take part
- Patients who expressed their preference for not having their data used for scientific research or to improve quality of care in the opt-out program of the CZE
Eligibility questionnaire
From the criteria published for this trial, to help you prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.
- Age
This trial is currently available in Netherlands.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
Cardiac arrhythmias frequently occur in patients admitted to the Coronary Care Unit (CCU). The majority of these patients are treated for an acute myocardial infarction, which carries an increased risk of life-threatening arrhythmias such as ventricular tachycardia (VT) or ventricular fibrillation (VF). This risk is one of the reasons these patients are monitored for 48 hours after a myocardial infarction, in accordance with the guidelines of the European Society of Cardiology (ESC) for acute coronary syndrome. Other arrhythmias, such as asystole, atrial fibrillation, or atrioventricular block, also occur in CCU patients. These arrhythmias are recorded on the electrocardiogram (ECG) monitor in the CCU and trigger an alarm for healthcare staff. However, in order to apply this alarming with sufficient sensitivity, many false positive alarms are also produced, which increases the workload for nurses (alarm fatigue) and undermines patient well-being.
Read full original descriptionShow less
This study will investigate whether Artificial Intelligence (AI) models, using continuous ECG data, can help improve the prediction of patients at risk of a life-threatening cardiac arrhythmia. Firstly, this study will aim to predict patients at risk of VT/VF in both the short term (30 minutes) and long term (1 day) in patients under continuous telemetric monitoring. This prediction facilitates timely intervention by the team in the short term, and in the long term, the safe transfer of a patient to a lower-complexity ward or earlier safe discharge of a patient. Secondly, this study will aim for improved detection to reduce the number of false negative alarms and thereby reduce alarm fatigue.
The performance of these AI models can be evaluated through this retrospective observational study. Patients aged 18 years or older who have been admitted with acute cardiac disease will be included. The primary objective of this study will be to evaluate the performance of AI models that detect and predict critical arrhythmias in the short and long term, using ECG data obtained via the monitoring system.
The group in the trial
- Adult patients admitted for acute cardiac illness/elective cardiac procedures on ECG monitoring
Next steps
For your doctor
Doctor ask sheet
A PDF for your doctor: what this trial tests, who can take part, and 1 eligibility question with room for answers and notes.
PDF, US Letter, 1 to 2 pages. A4 size
For the study team
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Artificial Intelligence-based Prediction and Detection of Critical Arrhythmias in Acute Cardiac Illness.
- Plain-language title
- Using computer software to predict dangerous heart rhythms in people with a heart attackGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 14 November 2026.
- Criteria questions
- Built from NCT07792694, who can take part
- Record updated
- 28 August 2026